Which inhalation therapy is commonly used for patients with respiratory distress?

Bronchodilators are the inhalation therapy most commonly used for patients experiencing respiratory distress. These medications work by relaxing and widening the airways (bronchi and bronchioles), which facilitates easier airflow to the lungs. This is especially important in conditions such as asthma and chronic obstructive pulmonary disease (COPD), where airway constriction can lead to significant breathing difficulties.

By helping to open up narrowed airways and relieve symptoms like wheezing, coughing, and shortness of breath, bronchodilators enable patients to breathe more comfortably and efficiently during episodes of respiratory distress.

While corticosteroids can help reduce inflammation in the airways, they do not act as quickly as bronchodilators and are often used as a long-term management strategy rather than immediate relief. Antibiotics target infections and are not typically used for non-infectious respiratory distress. Mucolytics help thin mucus but do not address the underlying airway constriction that causes acute respiratory distress. Thus, bronchodilators are the preferred choice in urgent situations requiring immediate relief.